Global Breakthrough Therapy Drugs Market Research Report 2023

Report ID: 1989564 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Breakthrough Therapy Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Oncology
        1.2.3 Anti-Viral
        1.2.4 Neurology
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Breakthrough Therapy Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Services
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Breakthrough Therapy Drugs Market Perspective (2017-2028)
    2.2 Breakthrough Therapy Drugs Growth Trends by Region
        2.2.1 Breakthrough Therapy Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Breakthrough Therapy Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Breakthrough Therapy Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Breakthrough Therapy Drugs Market Dynamics
        2.3.1 Breakthrough Therapy Drugs Industry Trends
        2.3.2 Breakthrough Therapy Drugs Market Drivers
        2.3.3 Breakthrough Therapy Drugs Market Challenges
        2.3.4 Breakthrough Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Breakthrough Therapy Drugs Players by Revenue
        3.1.1 Global Top Breakthrough Therapy Drugs Players by Revenue (2017-2022)
        3.1.2 Global Breakthrough Therapy Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Breakthrough Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Breakthrough Therapy Drugs Revenue
    3.4 Global Breakthrough Therapy Drugs Market Concentration Ratio
        3.4.1 Global Breakthrough Therapy Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Breakthrough Therapy Drugs Revenue in 2021
    3.5 Breakthrough Therapy Drugs Key Players Head office and Area Served
    3.6 Key Players Breakthrough Therapy Drugs Product Solution and Service
    3.7 Date of Enter into Breakthrough Therapy Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Breakthrough Therapy Drugs Breakdown Data by Type
    4.1 Global Breakthrough Therapy Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Type (2023-2028)
5 Breakthrough Therapy Drugs Breakdown Data by Application
    5.1 Global Breakthrough Therapy Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Breakthrough Therapy Drugs Market Size (2017-2028)
    6.2 North America Breakthrough Therapy Drugs Market Size by Country (2017-2022)
    6.3 North America Breakthrough Therapy Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Breakthrough Therapy Drugs Market Size (2017-2028)
    7.2 Europe Breakthrough Therapy Drugs Market Size by Country (2017-2022)
    7.3 Europe Breakthrough Therapy Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Breakthrough Therapy Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Breakthrough Therapy Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Breakthrough Therapy Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Breakthrough Therapy Drugs Market Size (2017-2028)
    9.2 Latin America Breakthrough Therapy Drugs Market Size by Country (2017-2022)
    9.3 Latin America Breakthrough Therapy Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Breakthrough Therapy Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Breakthrough Therapy Drugs Introduction
        11.1.4 Merck Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Breakthrough Therapy Drugs Introduction
        11.2.4 Pfizer Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 AbbVie
        11.3.1 AbbVie Company Detail
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Breakthrough Therapy Drugs Introduction
        11.3.4 AbbVie Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.3.5 AbbVie Recent Development
    11.4 Bristol-Myers Squibb Company
        11.4.1 Bristol-Myers Squibb Company Company Detail
        11.4.2 Bristol-Myers Squibb Company Business Overview
        11.4.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Introduction
        11.4.4 Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Company Recent Development
    11.5 Genentech
        11.5.1 Genentech Company Detail
        11.5.2 Genentech Business Overview
        11.5.3 Genentech Breakthrough Therapy Drugs Introduction
        11.5.4 Genentech Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.5.5 Genentech Recent Development
    11.6 Gilead
        11.6.1 Gilead Company Detail
        11.6.2 Gilead Business Overview
        11.6.3 Gilead Breakthrough Therapy Drugs Introduction
        11.6.4 Gilead Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.6.5 Gilead Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Detail
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Breakthrough Therapy Drugs Introduction
        11.7.4 Novartis Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.7.5 Novartis Recent Development
    11.8 Vertex Pharmaceuticals Incorporated
        11.8.1 Vertex Pharmaceuticals Incorporated Company Detail
        11.8.2 Vertex Pharmaceuticals Incorporated Business Overview
        11.8.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Introduction
        11.8.4 Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2017-2022)
        11.8.5 Vertex Pharmaceuticals Incorporated Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Breakthrough Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Oncology
    Table 3. Key Players of Anti-Viral
    Table 4. Key Players of Neurology
    Table 5. Key Players of Others
    Table 6. Global Breakthrough Therapy Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Breakthrough Therapy Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Breakthrough Therapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Breakthrough Therapy Drugs Market Share by Region (2017-2022)
    Table 10. Global Breakthrough Therapy Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Breakthrough Therapy Drugs Market Share by Region (2023-2028)
    Table 12. Breakthrough Therapy Drugs Market Trends
    Table 13. Breakthrough Therapy Drugs Market Drivers
    Table 14. Breakthrough Therapy Drugs Market Challenges
    Table 15. Breakthrough Therapy Drugs Market Restraints
    Table 16. Global Breakthrough Therapy Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Breakthrough Therapy Drugs Market Share by Players (2017-2022)
    Table 18. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy Drugs as of 2021)
    Table 19. Ranking of Global Top Breakthrough Therapy Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Breakthrough Therapy Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Breakthrough Therapy Drugs Product Solution and Service
    Table 23. Date of Enter into Breakthrough Therapy Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Breakthrough Therapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Breakthrough Therapy Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Breakthrough Therapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2017-2022)
    Table 31. Global Breakthrough Therapy Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2023-2028)
    Table 33. North America Breakthrough Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Breakthrough Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Breakthrough Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Breakthrough Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Breakthrough Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Breakthrough Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Breakthrough Therapy Drugs Product
    Table 46. Merck Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. Pfizer Company Detail
    Table 49. Pfizer Business Overview
    Table 50. Pfizer Breakthrough Therapy Drugs Product
    Table 51. Pfizer Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 52. Pfizer Recent Development
    Table 53. AbbVie Company Detail
    Table 54. AbbVie Business Overview
    Table 55. AbbVie Breakthrough Therapy Drugs Product
    Table 56. AbbVie Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 57. AbbVie Recent Development
    Table 58. Bristol-Myers Squibb Company Company Detail
    Table 59. Bristol-Myers Squibb Company Business Overview
    Table 60. Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product
    Table 61. Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 62. Bristol-Myers Squibb Company Recent Development
    Table 63. Genentech Company Detail
    Table 64. Genentech Business Overview
    Table 65. Genentech Breakthrough Therapy Drugs Product
    Table 66. Genentech Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 67. Genentech Recent Development
    Table 68. Gilead Company Detail
    Table 69. Gilead Business Overview
    Table 70. Gilead Breakthrough Therapy Drugs Product
    Table 71. Gilead Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 72. Gilead Recent Development
    Table 73. Novartis Company Detail
    Table 74. Novartis Business Overview
    Table 75. Novartis Breakthrough Therapy Drugs Product
    Table 76. Novartis Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 77. Novartis Recent Development
    Table 78. Vertex Pharmaceuticals Incorporated Company Detail
    Table 79. Vertex Pharmaceuticals Incorporated Business Overview
    Table 80. Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Product
    Table 81. Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 82. Vertex Pharmaceuticals Incorporated Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Breakthrough Therapy Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Oncology Features
    Figure 3. Anti-Viral Features
    Figure 4. Neurology Features
    Figure 5. Others Features
    Figure 6. Global Breakthrough Therapy Drugs Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Ambulatory Services Case Studies
    Figure 10. Breakthrough Therapy Drugs Report Years Considered
    Figure 11. Global Breakthrough Therapy Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Breakthrough Therapy Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Breakthrough Therapy Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Breakthrough Therapy Drugs Market Share by Players in 2021
    Figure 15. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Breakthrough Therapy Drugs Revenue in 2021
    Figure 17. North America Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Breakthrough Therapy Drugs Market Share by Country (2017-2028)
    Figure 19. United States Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Breakthrough Therapy Drugs Market Share by Country (2017-2028)
    Figure 23. Germany Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Breakthrough Therapy Drugs Market Share by Region (2017-2028)
    Figure 31. China Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Breakthrough Therapy Drugs Market Share by Country (2017-2028)
    Figure 39. Mexico Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Breakthrough Therapy Drugs Market Share by Country (2017-2028)
    Figure 43. Turkey Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Breakthrough Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Merck Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 46. Pfizer Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 47. AbbVie Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 49. Genentech Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 50. Gilead Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 51. Novartis Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 52. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Breakthrough Therapy Drugs Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Pfizer
AbbVie
Bristol-Myers Squibb Company
Genentech
Gilead
Novartis
Vertex Pharmaceuticals Incorporated
Frequently Asked Questions
Breakthrough Therapy Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Breakthrough Therapy Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Breakthrough Therapy Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports